Skip to main navigation Skip to search Skip to main content

EP0162: A Double-blind, Randomized, Placebo-controled, Multicenter, Outpatient, Parallel-group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older with Stereotypical Prolonged Seizures

Grants and Contracts Details

StatusFinished
Effective start/end date6/20/23 → 10/31/25

Funding

  • UCB Pharma (domestic): $15,275.00